Cargando…

Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models

SIMPLE SUMMARY: Colorectal cancer (CRC) is the second most common cancer worldwide. Despite improvements in the clinical management of CRC, outcomes for those with metastatic disease remain extremely poor. One reason for this is tumour heterogeneity, which refers to the observation that each cell wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shembrey, Carolyn, Smith, Jai, Grandin, Mélodie, Williams, Nathalia, Cho, Hyun-Jung, Mølck, Christina, Behrenbruch, Corina, Thomson, Benjamin NJ., Heriot, Alexander G., Merino, Delphine, Hollande, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833441/
https://www.ncbi.nlm.nih.gov/pubmed/35158849
http://dx.doi.org/10.3390/cancers14030581
_version_ 1784648942285225984
author Shembrey, Carolyn
Smith, Jai
Grandin, Mélodie
Williams, Nathalia
Cho, Hyun-Jung
Mølck, Christina
Behrenbruch, Corina
Thomson, Benjamin NJ.
Heriot, Alexander G.
Merino, Delphine
Hollande, Frédéric
author_facet Shembrey, Carolyn
Smith, Jai
Grandin, Mélodie
Williams, Nathalia
Cho, Hyun-Jung
Mølck, Christina
Behrenbruch, Corina
Thomson, Benjamin NJ.
Heriot, Alexander G.
Merino, Delphine
Hollande, Frédéric
author_sort Shembrey, Carolyn
collection PubMed
description SIMPLE SUMMARY: Colorectal cancer (CRC) is the second most common cancer worldwide. Despite improvements in the clinical management of CRC, outcomes for those with metastatic disease remain extremely poor. One reason for this is tumour heterogeneity, which refers to the observation that each cell within complex tumour cell populations displays different genetic features and biological behaviours. Such tumour heterogeneity is known to impact treatment efficacy and promote tumour recurrence. Here, we present a multi-colour barcoding methodology that allows for different lineages of colorectal cancer cells to be identified and monitored, thus allowing for tumour heterogeneity to be quantified in real-time. We show that discrete cell lineages can be quantified by both fluorescence microscopy and flow cytometry. Using this approach, we show that the cell culture models that are traditionally used in cancer research display limited heterogeneity, whereas patient-derived organoids—which are generated from fresh tumour resections—more faithfully represent the heterogeneity observed in cancer patients. ABSTRACT: Geno- and phenotypic heterogeneity amongst cancer cell subpopulations are established drivers of treatment resistance and tumour recurrence. However, due to the technical difficulty associated with studying such intra-tumoural heterogeneity, this phenomenon is seldom interrogated in conventional cell culture models. Here, we employ a fluorescent lineage technique termed “optical barcoding” (OBC) to perform simultaneous longitudinal tracking of spatio-temporal fate in 64 patient-derived colorectal cancer subclones. To do so, patient-derived cancer cell lines and organoids were labelled with discrete combinations of reporter constructs, stably integrated into the genome and thus passed on from the founder cell to all its clonal descendants. This strategy enables the longitudinal monitoring of individual cell lineages based upon their unique optical barcodes. By designing a novel panel of six fluorescent proteins, the maximum theoretical subpopulation resolution of 64 discriminable subpopulations was achieved, greatly improving throughput compared with previous studies. We demonstrate that all subpopulations can be purified from complex clonal mixtures via flow cytometry, permitting the downstream isolation and analysis of any lineages of interest. Moreover, we outline an optimized imaging protocol that can be used to image optical barcodes in real-time, allowing for clonal dynamics to be resolved in live cells. In contrast with the limited intra-tumour heterogeneity observed in conventional 2D cell lines, the OBC technique was successfully used to quantify dynamic clonal expansions and contractions in 3D patient-derived organoids, which were previously demonstrated to better recapitulate the heterogeneity of their parental tumour material. In summary, we present OBC as a user-friendly, inexpensive, and high-throughput technique for monitoring intra-tumoural heterogeneity in in vitro cell culture models.
format Online
Article
Text
id pubmed-8833441
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88334412022-02-12 Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models Shembrey, Carolyn Smith, Jai Grandin, Mélodie Williams, Nathalia Cho, Hyun-Jung Mølck, Christina Behrenbruch, Corina Thomson, Benjamin NJ. Heriot, Alexander G. Merino, Delphine Hollande, Frédéric Cancers (Basel) Article SIMPLE SUMMARY: Colorectal cancer (CRC) is the second most common cancer worldwide. Despite improvements in the clinical management of CRC, outcomes for those with metastatic disease remain extremely poor. One reason for this is tumour heterogeneity, which refers to the observation that each cell within complex tumour cell populations displays different genetic features and biological behaviours. Such tumour heterogeneity is known to impact treatment efficacy and promote tumour recurrence. Here, we present a multi-colour barcoding methodology that allows for different lineages of colorectal cancer cells to be identified and monitored, thus allowing for tumour heterogeneity to be quantified in real-time. We show that discrete cell lineages can be quantified by both fluorescence microscopy and flow cytometry. Using this approach, we show that the cell culture models that are traditionally used in cancer research display limited heterogeneity, whereas patient-derived organoids—which are generated from fresh tumour resections—more faithfully represent the heterogeneity observed in cancer patients. ABSTRACT: Geno- and phenotypic heterogeneity amongst cancer cell subpopulations are established drivers of treatment resistance and tumour recurrence. However, due to the technical difficulty associated with studying such intra-tumoural heterogeneity, this phenomenon is seldom interrogated in conventional cell culture models. Here, we employ a fluorescent lineage technique termed “optical barcoding” (OBC) to perform simultaneous longitudinal tracking of spatio-temporal fate in 64 patient-derived colorectal cancer subclones. To do so, patient-derived cancer cell lines and organoids were labelled with discrete combinations of reporter constructs, stably integrated into the genome and thus passed on from the founder cell to all its clonal descendants. This strategy enables the longitudinal monitoring of individual cell lineages based upon their unique optical barcodes. By designing a novel panel of six fluorescent proteins, the maximum theoretical subpopulation resolution of 64 discriminable subpopulations was achieved, greatly improving throughput compared with previous studies. We demonstrate that all subpopulations can be purified from complex clonal mixtures via flow cytometry, permitting the downstream isolation and analysis of any lineages of interest. Moreover, we outline an optimized imaging protocol that can be used to image optical barcodes in real-time, allowing for clonal dynamics to be resolved in live cells. In contrast with the limited intra-tumour heterogeneity observed in conventional 2D cell lines, the OBC technique was successfully used to quantify dynamic clonal expansions and contractions in 3D patient-derived organoids, which were previously demonstrated to better recapitulate the heterogeneity of their parental tumour material. In summary, we present OBC as a user-friendly, inexpensive, and high-throughput technique for monitoring intra-tumoural heterogeneity in in vitro cell culture models. MDPI 2022-01-24 /pmc/articles/PMC8833441/ /pubmed/35158849 http://dx.doi.org/10.3390/cancers14030581 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shembrey, Carolyn
Smith, Jai
Grandin, Mélodie
Williams, Nathalia
Cho, Hyun-Jung
Mølck, Christina
Behrenbruch, Corina
Thomson, Benjamin NJ.
Heriot, Alexander G.
Merino, Delphine
Hollande, Frédéric
Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models
title Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models
title_full Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models
title_fullStr Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models
title_full_unstemmed Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models
title_short Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models
title_sort longitudinal monitoring of intra-tumoural heterogeneity using optical barcoding of patient-derived colorectal tumour models
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833441/
https://www.ncbi.nlm.nih.gov/pubmed/35158849
http://dx.doi.org/10.3390/cancers14030581
work_keys_str_mv AT shembreycarolyn longitudinalmonitoringofintratumouralheterogeneityusingopticalbarcodingofpatientderivedcolorectaltumourmodels
AT smithjai longitudinalmonitoringofintratumouralheterogeneityusingopticalbarcodingofpatientderivedcolorectaltumourmodels
AT grandinmelodie longitudinalmonitoringofintratumouralheterogeneityusingopticalbarcodingofpatientderivedcolorectaltumourmodels
AT williamsnathalia longitudinalmonitoringofintratumouralheterogeneityusingopticalbarcodingofpatientderivedcolorectaltumourmodels
AT chohyunjung longitudinalmonitoringofintratumouralheterogeneityusingopticalbarcodingofpatientderivedcolorectaltumourmodels
AT mølckchristina longitudinalmonitoringofintratumouralheterogeneityusingopticalbarcodingofpatientderivedcolorectaltumourmodels
AT behrenbruchcorina longitudinalmonitoringofintratumouralheterogeneityusingopticalbarcodingofpatientderivedcolorectaltumourmodels
AT thomsonbenjaminnj longitudinalmonitoringofintratumouralheterogeneityusingopticalbarcodingofpatientderivedcolorectaltumourmodels
AT heriotalexanderg longitudinalmonitoringofintratumouralheterogeneityusingopticalbarcodingofpatientderivedcolorectaltumourmodels
AT merinodelphine longitudinalmonitoringofintratumouralheterogeneityusingopticalbarcodingofpatientderivedcolorectaltumourmodels
AT hollandefrederic longitudinalmonitoringofintratumouralheterogeneityusingopticalbarcodingofpatientderivedcolorectaltumourmodels